Flow chart outlining the different phases of the study. Two phases of the study were performed. In phase 1, the identification of candidate somatic mutations by WES was carried out in an index patient. BCOR mutations were subsequently searched for in 82 CN-AML patients with the same genotype as the AML index patient. In phase 2 of the study, additional patient cohorts and associations between BCOR and other molecular mutations were investigated.